Table 2.

Reported cases of simultaneous consumption of SCRAs and ethanol

Age (y)/Sex	SCRA and concentration	BAC	Study
33/F	5F-MDMB-PICA 1.7 ng/mL	2.2 g/L	Kleis et al. [21]
25/M	5F-PB-22 0.37 ng/mL	2.5 g/L	Angerer et al. [22]
28/M	AB-CHMINACA 4.1 ng/mL	1.45 g/L	Angerer et al. [22]
30/M	AB-CHMINACA 1.5 ng/mL	1.8 g/L	Gieron et al. [23]
51/M	Cumyl-PEGACLONE 0.73 ng/mL	2.7 g/L	Tiemensma et al. [24]
50/M	Cumyl-PEGACLONE 3.0 ng/mL	2.4 g/L	Tiemensma et al. [24]
33/M	Cumyl-PEGACLONE 2.0 ng/mL	2.4 g/L	Tiemensma et al. [24]